老年原发性胆汁性肝硬化患者的特点

doi:10.3969/.j.issn.1672-5069.2015.06.002

Abstract

Wang Gui， Wang Jiangbin.. Features of elderly patients with primary biliary cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 573-574.

[1] Gershwin ME,Selmi C,Worman HJ,et al.Risk factors and comorbidities in primary biliary cirrhosis：a controlled interview based study of 1032 patient.Hepatology,2005,42（5）：1194-1202.
[2] Ala A,Stanca CM. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology,2006,43（3）：525-531.
[3] Selmi C,Mayo MJ,Bach N,et al.Primary biliary cirrhosis in monozygotic and dizygotic twins：genetics,epigenetics,and environment.Gastroenterology,2004,127：485-492.
[4] Lindor KD,Gershwin ME,Poupon R,et al.Primary biliary cirrhosis.Hepatology,2009,50：291-308.
[5] Geier MR,Geier DA.A case-series of adverse events,positive rechallenge of symptoms,and events in identical twins following hepatitis B vaccination：analysis of vaccine adverse event reporting system（VAERS） database and literature review. Clin Exp Rheumatol,2004,22（6）：749-755.
[6] Leung PS,Park O,Tsuneyama K,et al.Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.Immunology,2007,179：2651-2657.
[7] Zein CO,Angulo P,Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis. Clin Gastroenterol Hepatol,2003,1：89-95.
[8] Corpechot C,ElNaggar A,Poujol-Robert A,et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology,2006,43：1118-1124.
[9] Prince MI,Chetwynd A,Craig WL,et al. Asymptomatic primary biliary cirrhosis：clinical features,prognosis,and symptom progression in a large population based cohort.Gut,2004,53：865-870.
[10] Forton DM,Patel N,Prince M,et al. Fatigue and primary biliary cirrhosis：association of globus pallidus magnetization transfer ratio measurements with fatigue severity and blood manganese levels. Gut,2004,3：587-592.
[11] Newton JL,Jones DE. Modanil is effective treatment for excessive daytime somnolence and fatigue in primary biliary cirrhosis. Hepatology,2006,44：628A.
[12] Poupon RE,Chretien Y,Chazouilleres O,et al.Quality of life in patients with primary biliary cirrhosis. Hepatology,2004,40：489-494.
[13] Pares A,Caballeria L,Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid.Gastroenterology,2006,130：715-720.
[14] Corpechot C,Carrat F,Bahr A,et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.Gastroenterology,2005,128：297-203.
[15] Boberg KM,Wisloff T,Kjollesdal KS,et al. Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.Aliment Pharmacol Ther,2013,38（7）：794-803.

Features of elderly patients with primary biliary cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[2]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[3]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[4]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[5]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[6]	Liu Yingchuan, Zhao Pengcheng, You Ting, et al.. Changes of peripheral blood 25-（OH） 2-D3 levels and peripheral T lymphocyte subsets in patients with primary biliary cirrhosis receiving vitamin D supplementation and ursodeoxycholic acid treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 907-910.
[7]	Liu Jinguo, Wang Baokui. Efficacy of Fufangbiejia Ruanganpian and ursodeoxycholic acid combination in the treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 340-343.
[8]	Li Min, Li Hong, Fu Zhiyue. Efficacy of adenosylmethionine combined with ursodeoxycholic acid in treatment of infants with cytomegalovirus infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 461-462.
[9]	Qin Wei, Chen Yuping, Yang Zhao, et al. Expression of transforming growth factor β-1 in liver tissues of patients with primary biliary cirrhosis and its relationship with liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 237-240.
[10]	Chen Xiaojun, Song Yang. Changes of peripheral blood T lymphocyte subsets and efficacy of ursodesoxycholic acid and vitamin D combination in treatment of patients with primary biliary cholangitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 80-83.
[11]	Tao Mingling, Zhang Shibin, Wu Yanjing, et al.. Non-invasive predictors of esophageal varices in patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 439-442.
[12]	Liu Funa, Liu Jiangkui, Shen Yihui.. Efficacy of ursodeoxycholic acid and prednisolone combination in treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 443-446.
[13]	Jiang Hao, Ge Hongyan.. Clinical efficacy of ursodeoxycholic acid combined with fat-soluble vitamin in treatment of patients with alcoholic liver disease and intrahepatic cholestasis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 105-106.
[14]	Guo Rui, Tan Jin.. A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 109-110.
[15]	Han Yongbin， Liu Xin，Wang Aifang， et al.. Primary biliary cirrhosis misdiagnosed as bone marrow hyperplasia syndrome: A case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 747-748.